Institution · Ablynx (Belgium)
Most cited papers from Ablynx (Belgium)
What are the most cited papers from Ablynx (Belgium)?
The most cited paper from Ablynx (Belgium) is "Control of coleopteran insect pests through RNA interference" (James A. Baum, Thierry Bogaert, William P. Clinton et al., 2007), with 1,816 citations. Next come "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura" (1,038) and "Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)" (1,014).
Showing 50 of 60 papers. Every paper with more than 155 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Control of coleopteran insect pests through RNA interference James A. Baum, Thierry Bogaert, William P. Clinton et al. · Nature Biotechnology | Nov 2007 | 1,816 |
| 2 | Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero R. Cataland, Flora Peyvandi et al. · New England Journal of Medicine | 9 Jan 2019 | 1,038 |
| 3 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza et al. · European Journal of Immunology | Oct 2019 | 1,014 |
| 4 | Selecting and screening recombinant antibody libraries Hennie R. Hoogenboom · Nature Biotechnology | Sep 2005 | 978 |
| 5 | Properties, production, and applications of camelid single-domain antibody fragments Michiel M. Harmsen, Hans J. de Haard · Applied Microbiology and Biotechnology | 17 Aug 2007 | 816 |
| 6 | Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology Nicholas J. Ashton, Tharick Ali Pascoal, Thomas K. Karikari et al. · Acta Neuropathologica | 14 Feb 2021 | 755 |
| 7 | Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies Erwin De Genst, Karen Silence, Klaas Decanniere et al. · Proceedings of the National Academy of Sciences | 13 Mar 2006 | 691 |
| 8 | Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells Hsing-Chen Tsai et al. · Cancer Cell | Mar 2012 | 658 |
| 9 | The roots of a new green revolution Griet Den Herder, Gert Van Isterdael, Tom Beeckman et al. · Trends in Plant Science | 18 Sep 2010 | 520 |
| 10 | Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice Falk Hildebrand, Thi Loan Anh Nguyen, Brigitta M. N. Brinkman et al. · Genome biology | 24 Jan 2013 | 485 |
| 11 | Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring Nicholas James Ashton et al. · Nature Medicine | Dec 2022 | 458 |
| 12 | Animal models in translational medicine: Validation and prediction Tinneke Denayer, Thomas Stöhr, Maarten Van Roy · European Journal of Molecular & Clinical Medicine | 27 Aug 2014 | 453 |
| 13 | NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling Yves Dondelinger, Sandrine Jouan-Lanhouet, Tatyana Divert et al. · Molecular Cell | 4 Sep 2015 | 440 |
| 14 | Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans Peter Ulrichts, Antonio Guglietta, Torsten Dreier et al. · Journal of Clinical Investigation | 24 Jul 2018 | 415 |
| 15 | Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis Laetitia Devy et al. · Cancer Research | 11 Feb 2009 | 357 |
| 16 | Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies Rob C. Roovers, Toon Laeremans, Lieven Huang et al. · Cancer Immunology Immunotherapy | 29 May 2006 | 352 |
| 17 | Molecular Mechanisms and Pathophysiology of Necrotic Cell Death Nele Vanlangenakker, Tom Vanden Berghe, Dmitri V. Krysko et al. · Current Molecular Medicine | 30 Apr 2008 | 347 |
| 18 | Degradation of Deep-Eutectic Solvents Based on Choline Chloride and Carboxylic Acids Nerea Rodriguez Rodriguez, Adriaan van den Bruinhorst, Laura J. B. M. Kollau et al. · ACS Sustainable Chemistry & Engineering | 28 May 2019 | 318 |
| 19 | Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis Ken T. Coppieters, Torsten Dreier, Karen Silence et al. · Arthritis & Rheumatism | 30 May 2006 | 307 |
| 20 | Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology Bernard M. Tijink, Toon Laeremans, Marianne Budde et al. · Molecular Cancer Therapeutics | Aug 2008 | 305 |
| 21 | Chemistry of Crosslinking Processes for Self‐Healing Polymers Stijn Billiet, Xander K. D. Hillewaere, Roberto F. A. Teixeira et al. · Macromolecular Rapid Communications | 17 Dec 2012 | 302 |
| 22 | Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy | 5 Oct 2015 | 299 |
| 23 | X-ray computed tomography proof of bacterial-based self-healing in concrete Jianyun Wang, Jan Dewanckele, Veerle Cnudde et al. · Cement and Concrete Composites | 21 Jul 2014 | 295 |
| 24 | Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al. · Mucosal Immunology | 30 Sep 2009 | 291 |
| 25 | A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth Rob C. Roovers, Maria J.W.D. Vosjan, Toon Laeremans et al. · International Journal of Cancer | 25 Apr 2011 | 290 |
| 26 | FRET‐based genetically encoded sensors allow high‐resolution live cell imaging of Ca 2+ dynamics Melanie Krebs, Katrin Held, Andreas Binder et al. · The Plant Journal | 12 Sep 2011 | 281 |
| 27 | Grand challenges for Smoothed Particle Hydrodynamics numerical schemes Renato Vacondio, Corrado Altomare, M. de Leffe et al. · Computational Particle Mechanics | 19 Sep 2020 | 267 |
| 28 | Nanophotonic Pockels modulators on a silicon nitride platform Koen Alexander, John P. George, Jochem Verbist et al. · Nature Communications | 21 Aug 2018 | 261 |
| 29 | CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells Sven Jähnichen, Christophe Blanchetot, David Maussang et al. · Proceedings of the National Academy of Sciences | 8 Nov 2010 | 257 |
| 30 | Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs Stefan S. De Buck, Vikash K. Sinha, Luca A. Fenu et al. · Drug Metabolism and Disposition | 10 Jul 2007 | 255 |
| 31 | Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays Nicholas James Ashton et al. · Alzheimer s & Dementia | 12 Nov 2022 | 239 |
| 32 | The HAC1 gene from Pichia pastoris: characterization and effect of its overexpression on the production of secreted, surface displayed and membrane proteins Mouna Guerfal, Stefan Ryckaert, Pieter P. Jacobs et al. · Microbial Cell Factories | 30 Jun 2010 | 230 |
| 33 | CD70: An emerging target in cancer immunotherapy Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel et al. · Pharmacology & Therapeutics | 26 Jul 2015 | 228 |
| 34 | Comparison of different approaches for self-healing concrete in a large-scale lab test Kim Van Tittelboom, Jianyun Wang, Maria Adelaide Pereira Gomes de Araújo et al. · Construction and Building Materials | 11 Jan 2016 | 226 |
| 35 | Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer Geert Berx, Eric Raspé, Gerhard Christofori et al. · Clinical & Experimental Metastasis | Nov 2007 | 225 |
| 36 | T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1 Jens Staal, Yasmine Driege, Tine Bekaert et al. · The EMBO Journal | 29 Mar 2011 | 222 |
| 37 | Active site engineering in UiO-66 type metal–organic frameworks by intentional creation of defects: a theoretical rationalization Matthias Vandichel, Julianna Hajek, Frederik Vermoortele et al. · CrystEngComm | 15 Sep 2014 | 218 |
| 38 | Fifteen chemistries for autonomous external self-healing polymers and composites Xander K. D. Hillewaere, Filip Du Prez · Progress in Polymer Science | 16 Apr 2015 | 217 |
| 39 | The CD70-CD27 axis in oncology: the new kids on the block Tal Flieswasser, Astrid Van den Eynde, Jonas R.M. Van Audenaerde et al. · Journal of Experimental & Clinical Cancer Research | 6 Jan 2022 | 216 |
| 40 | Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents Carsten Riether et al. · Nature Medicine | 29 Jun 2020 | 216 |
| 41 | Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk et al. · Alzheimer s Research & Therapy | Dec 2021 | 205 |
| 42 | Effect of post-treatments on the fatigue behaviour of 316L stainless steel manufactured by laser powder bed fusion Chola Elangeswaran, Antonio Cutolo, Gokula Krishna Muralidharan et al. · International Journal of Fatigue | 4 Feb 2019 | 201 |
| 43 | Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules Anna Hultberg, Nigel James Temperton, Valérie Rosseels et al. · PLoS ONE | Apr 2011 | 199 |
| 44 | SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression Lieven Huang, Lea Olive Tchouate Gainkam, Vicky Caveliers et al. · Molecular Imaging and Biology | 22 Feb 2008 | 193 |
| 45 | Cumulative Damage and Life Prediction Models for High-Cycle Fatigue of Metals: A Review Kris Hectors, Wim De Waele · Metals | 22 Jan 2021 | 191 |
| 46 | The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy | 20 May 2015 | 184 |
| 47 | Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia Adrian C. Newland, Blanca Sánchez‐González, László Rejtő et al. · American Journal of Hematology | 10 Dec 2019 | 183 |
| 48 | Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases Gino Van Heeke, Koen Allosery, Veronique De Brabandere et al. · Pharmacology & Therapeutics | 2 Jul 2016 | 183 |
| 49 | Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs Hans Ulrichts, Karen Silence, Anne Schoolmeester et al. · Blood | 17 May 2011 | 183 |
| 50 | Aceros avanzados de alta resistencia en la industria automovilística J. Galán, Ludovic Samek, Patricia Verleysen et al. · Revista de Metalurgia | 30 Apr 2012 | 183 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.